Literature DB >> 12397851

Pharmacological applications of magnetic resonance imaging.

Betty Jo Salmeron1, Elliot A Stein.   

Abstract

Magnetic resonance imaging (MRI) techniques are capable of spatial and temporal resolution and within subject repeatability that far exceed other currently available methods of noninvasively investigating brain functioning. While functional MRI (fMRI) techniques have traditionally been used to investigate sensory, motor, and cognitive functions, they are also very attractive for investigating the effects of pharmacological agents in the brain. However, because pharmacological agents may interfere with the very mechanisms that give rise to the fMRI signal, careful attention to experimental design and data analysis issues must be exercised. Specifically, introducing a drug into the system could potentially alter the coupling of neural activity with regional cerebral blood flow and/or the extraction of oxygen from blood, or may cause local or global cardiovascular changes unrelated to neural activity. These concerns notwithstanding, careful attention to experimental detail and verification procedures promises to make pharmacological MRI a valuable tool for understanding the actions of drugs on the brain at many levels. The physiological and biophysical bases of blood oxygen level-dependent, arterial spin labeling, cerebral blood flow, cerebral blood volume, and spectroscopy acquisition methods are presented to illustrate where confounds may arise when a drug is added to the system. Selected studies combining administration of pharmacological agents with MRI techniques are critically reviewed to illustrate both the challenges inherent in these applications and some possible solutions. Included are studies of acute direct effects of drugs, effects of drugs on task-related activation, chronic effects of drugs, effects of drugs on cerebral metabolism, and variable effects of drugs in different populations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12397851

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  13 in total

1.  Neurobiological impact of nicotinic acetylcholine receptor agonists: an activation likelihood estimation meta-analysis of pharmacologic neuroimaging studies.

Authors:  Matthew T Sutherland; Kimberly L Ray; Michael C Riedel; Julio A Yanes; Elliot A Stein; Angela R Laird
Journal:  Biol Psychiatry       Date:  2015-01-07       Impact factor: 13.382

2.  Region-specific effects of isoflurane anesthesia on Fos immunoreactivity in response to intravenous cocaine challenge in rats with a history of repeated cocaine administration.

Authors:  Peter R Kufahl; Natalie A Peartree; Krista L Heintzelman; Maggie Chung; Janet L Neisewander
Journal:  Brain Res       Date:  2014-10-22       Impact factor: 3.252

3.  Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia.

Authors:  Céline Risterucci; Karine Jeanneau; Stephanie Schöppenthau; Thomas Bielser; Basil Künnecke; Markus von Kienlin; Jean-Luc Moreau
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

4.  Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging.

Authors:  Nicholas Jones; Michael J O'Neill; Mark Tricklebank; Vincenzo Libri; Steve C R Williams
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

5.  Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans.

Authors:  Oliver G Bosch; Fabrizio Esposito; Michael M Havranek; Dario Dornbierer; Robin von Rotz; Philipp Staempfli; Boris B Quednow; Erich Seifritz
Journal:  Neuropsychopharmacology       Date:  2017-05-31       Impact factor: 7.853

6.  Smoking status as a potential confound in the BOLD response of patients with schizophrenia.

Authors:  Leonard Leyba; Andrew R Mayer; Randy L Gollub; Nancy C Andreasen; Vincent P Clark
Journal:  Schizophr Res       Date:  2008-08-05       Impact factor: 4.939

7.  Differential effects of acute cocaine and placebo administration on visual cortical activation in healthy subjects measured using BOLD fMRI.

Authors:  Steven B Lowen; Lisa D Nickerson; Jonathan M Levin
Journal:  Pharmacol Biochem Behav       Date:  2008-12-24       Impact factor: 3.533

8.  Mapping the central effects of ketamine in the rat using pharmacological MRI.

Authors:  Clare L Littlewood; Nicholas Jones; Michael J O'Neill; Stephen N Mitchell; Mark Tricklebank; Steven C R Williams
Journal:  Psychopharmacology (Berl)       Date:  2006-03-21       Impact factor: 4.530

Review 9.  Role of functional magnetic resonance imaging in drug discovery.

Authors:  Martin P Paulus; Murray B Stein
Journal:  Neuropsychol Rev       Date:  2007-04-10       Impact factor: 7.444

10.  Use of fMRI to predict psychiatric adverse effects of interferon treatment for Hepatitis C - preliminary report.

Authors:  Donald H Marks; Mehdi Adineh; Binquan Wang; Sudeepa Gupta
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.